Dr. Yuval Cabilly is co-founder and Managing Partner of Israel Biotech Fund, a venture capital fund investing in exceptional Israeli pharmaceutical companies. Dr. Cabilly serves on the Board of Directors of Pharma Two B and Tamarix. He is also co-founder and Board Member of 8400 – The Health Network. Dr. Cabilly received his PhD in molecular cell biology from the Tel Aviv University. His research focused on neurodegenerative diseases.